Chiniara Ellen — SEC Form 4 filings
SEC reporting owner CIK 1398764. 6 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-14 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 5,370 shares, $198,884 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 3,129 shares @ $41.75 ($130,645) in Kymera Therapeutics, Inc., filed 2025-01-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Chief Legal Officer | 3 | — | 3 legs · 5,370 sh · $198,884 | 4 |
| Compass Therapeutics, Inc. (CMPX) | Director | 3 | — | — | 3 |
Form 4 filings — Chiniara Ellen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-05 | 4 | Compass Therapeutics, Inc. (CMPX) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 27,500 @ $0 · Sale (S): 1,833 @ $30.33 · Sale (S): 408 @ $31.00 · Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-02-13 | 4 | Compass Therapeutics, Inc. (CMPX) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Kymera Therapeutics, Inc. (KYMR) | Sale (S): 3,129 @ $41.75 | EDGAR |
| 2024-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 21,755 @ $0 · Grant/award (A): 130,531 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Compass Therapeutics, Inc. (CMPX) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1398764 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →